Who Needs a Skin Check, and How Often

Does everyone need a regular skin check?

Not on a fixed schedule — not if you have no symptoms and no risk factors. When the US Preventive Services Task Force last reviewed screening the whole population, it found the evidence insufficient to weigh the benefits and harms of routine whole-body skin exams by a clinician in asymptomatic teens and adults, and issued a Grade I statement 1Ref 1US Preventive Services Task Force (2023).Skin Cancer: Screening.The USPSTF 2023 Grade I statement that current evidence is insufficient to weigh the benefits and harms of routine whole-body clinical skin screening in asymptomatic adolescents and adults, and that screening carries potential harms such as biopsy and overtreatment.. A Grade I is easy to misread. It is not a recommendation against skin checks; it means the studies that would prove a net benefit for everyone have not been done 2Ref 2U.S. Preventive Services Task Force (2018).Grade Definitions.That a USPSTF Grade I means the evidence is insufficient to assess the balance of benefits and harms, which is distinct from a Grade D recommendation against a service.. Two things sit entirely outside that verdict. It says nothing about people at elevated risk, who were never the subject of the recommendation. And it says nothing about getting a specific, worrying spot examined — that is a diagnostic visit, not screening, and the case for it does not depend on any screening guideline.

It also helps to understand why the evidence is unsettled rather than simply thin. Screening is not free of harm. A whole-body exam can turn up harmless spots that lead to biopsies, small scars, anxiety, and occasionally the treatment of a lesion that would never have caused trouble — which is exactly what the Task Force weighs against the benefits, rather than assuming more screening is always better 1Ref 1US Preventive Services Task Force (2023).Skin Cancer: Screening.The USPSTF 2023 Grade I statement that current evidence is insufficient to weigh the benefits and harms of routine whole-body clinical skin screening in asymptomatic adolescents and adults, and that screening carries potential harms such as biopsy and overtreatment.. For a person at genuinely higher risk, that balance tilts toward checking, because the chance of finding something that matters is higher. For someone at average risk, the same exam turns up more false alarms per real cancer. None of this argues against getting a worrying spot looked at. It is the argument for matching how often you are screened to how much risk you actually carry.

the screening debate is about the average person with no risk factors, not about you if you carry a real one.

Why finding skin cancer early is the whole point

Early detection changes almost everything about how skin cancer is treated. Melanoma, the most dangerous of the common skin cancers, is highly survivable when it is found while still confined to the skin: five-year relative survival is around 99% for localized disease, and it falls sharply once the cancer has reached lymph nodes or distant organs 3Ref 3National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.That five-year relative survival for melanoma is very high when the cancer is localized and falls substantially once it has spread to regional lymph nodes or distant sites.. about 99% five-year relative survival for localized melanoma, far lower once it has spread 3Ref 3National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.That five-year relative survival for melanoma is very high when the cancer is localized and falls substantially once it has spread to regional lymph nodes or distant sites.. Basal cell and squamous cell carcinomas rarely spread, but they grow into and destroy nearby tissue, and finding one while it is small usually means a smaller, simpler repair with a better cosmetic result.

This is why the value of a skin check is not measured by finding cancer in everyone. It is measured by shortening the gap between the moment something changes and the moment a qualified person looks at it. Every part of the apparatus that follows — the risk groups, the intervals, the self-exam — exists to close that gap for the people in whom it is most likely to matter, and to avoid over-checking the people in whom it is not.

Who is at higher risk?

Some people carry enough risk that most dermatologists watch their skin on a set schedule, and risk stacks — the more of the following that apply, the stronger the case for regular professional checks. The single largest modifiable factor is ultraviolet exposure: sunlight, sunlamps, and tanning beds are the main preventable cause of skin cancer 4Ref 4National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.That ultraviolet radiation from sun, sunlamps, and tanning beds is the principal modifiable risk factor for skin cancer.. The rest of the picture reflects who is most likely to develop it:

• A prior skin cancer or precancer. Having had one melanoma, basal cell, or squamous cell carcinoma is among the strongest predictors of developing another, which is why people treated for one are followed closely afterward.
• Many moles, or unusual ones. A dysplastic (atypical) nevus — a mole that is larger, irregular in outline, or mottled in color — and a high overall mole count both raise melanoma risk.
• Fair, sun-sensitive skin. Skin that burns rather than tans, red or blond hair, light eyes, and easy freckling.
• A history of blistering sunburns, or any tanning-bed use.
• A first-degree relative with melanoma, or a known familial melanoma syndrome.
• A suppressed immune system — an organ transplant, or long-term immune-suppressing medication.

These factors are not equal, and they combine rather than simply adding up: fair skin plus a high mole count plus a family history is a very different risk picture from any one of them alone. Risk is not destiny, though. Regular sunscreen use is one of the few habits shown in a randomized trial to lower the melanoma rate, so prevention and surveillance pull in the same direction 5Ref 5Green AC, Williams GM, Logan V, Strutton GM (2011).Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up.That regular daily sunscreen use reduced the incidence of melanoma in long-term follow-up of a randomized trial, supporting UV protection as prevention.. the great majority of moles never become cancer — the point of watching is to catch the rare one early.

How often should each group be checked?

There is no universal interval, because the right frequency depends on how much risk you carry, not on the calendar. For someone with no risk factors and no symptoms, there is no evidence-based screening schedule at all — watching your own skin and raising anything new with a clinician is a reasonable approach. For higher-risk people, a dermatologist usually sets a personal interval and then adjusts it: often somewhere between every six and twelve months, sometimes closer after a recent skin cancer, and further apart during a long stretch with nothing new. The interval is a clinical judgment, revised as your history changes, not a number fixed for life.

Because of that, the most useful thing you can do at a visit is ask directly: given my history, how often do you want to see me, and what specifically should I watch for in between? A clear answer turns a vague worry into a plan you can follow, and it tells you which changes are worth an early call rather than waiting for the next scheduled check. the interval is set to your risk and revisited at every visit — there is no single correct number.

Checking your skin — at the clinic and at home

A skin check happens in two places — the clinic and your own bathroom — and the two work together. A professional exam is a systematic visual check of the skin from scalp to soles, usually taking ten to fifteen minutes. The clinician looks at the whole surface in good light, often with a dermatoscope — a handheld magnifier with a light that reveals patterns invisible to the naked eye — and pays particular attention to any spot you flag. Sun-exposed sites get close scrutiny, including the scalp, the ears, the nose, and the lips, high-risk sites where cancers are common and easy to overlook. If a lesion looks concerning, the next step is usually a biopsy: a small sample taken under local anesthetic and sent to a lab, because no exam alone, however expert, can confirm what a spot is. Some higher-risk patients also have total-body photography or mole mapping, so future exams can be compared against a baseline image rather than a memory.

Between those visits, a monthly self-exam is the highest-yield habit for most people. Undress fully in good light, use a hand mirror for the back and scalp, and look at every surface — including between the toes, the soles, the genitals, and under the nails, where sun has nothing to do with it and cancers can still appear. Two patterns are worth learning. The ABCDE features flag a mole that may need evaluation: Asymmetry, Border irregularity, Color that varies within a single spot, Diameter larger than about a pencil eraser, and Evolving — any change in size, shape, color, or sensation over weeks to months 6Ref 6Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE features (Asymmetry, Border irregularity, Color variegation, Diameter over about 6 mm, Evolving) as clinical criteria that flag a mole for evaluation.. The ugly-duckling sign is simpler still: a spot that looks or behaves unlike your others. These features raise concern; they cannot confirm or rule anything out. Only an in-person exam and, if needed, a biopsy can do that. photograph anything you are watching, so a change is measured against an image instead of a memory. The job of a self-exam is to notice, record, and report — never to reach a verdict.

Skin checks and skin of color

Skin cancer is less common in darker skin, but it is more often found at a later, harder-to-treat stage — which makes where you look at least as important as how often. In skin of color, melanoma disproportionately turns up as acral melanoma on the soles, palms, and nails, and inside the mouth, rather than on sun-exposed skin, so an exam that covers only the arms and face can miss the sites that matter most. A dark streak running the length of a nail, a new or changing spot on the sole of the foot, or a sore that will not heal deserves the same prompt attention on any skin tone. Anyone thinking about skin cancer in skin of color should make sure that both their own checks and any professional exam deliberately include the hands, feet, nails, and mouth. The later-stage pattern is not about biology alone; it is partly that these sites are less watched and these cancers less expected, which a deliberate, complete exam directly corrects.

Higher surveillance: transplants and a suppressed immune system

People whose immune systems are suppressed sit in the highest-surveillance group, and they are usually watched on a schedule set by their own specialists. The link between immunosuppression and skin cancer is strong: after an organ transplant, and with long-term immune-suppressing medicine, squamous cell carcinoma in particular becomes considerably more common and can behave more aggressively than it does in people with intact immunity. Because of that, transplant and dermatology teams generally arrange regular skin exams and act quickly on any new or changing spot. If this describes you, skin cancer after transplant is not a rare footnote but an expected risk to be managed over years. The frequency is individualized, and it is one of the clearest situations where routine professional checks are warranted — worth confirming with your team who is responsible for them, how often they want to see you, and how sun protection fits in, since UV exposure compounds an already elevated risk.

Free and low-cost skin checks, and what insurance covers

Cost should not be the reason a check does not happen. Volunteer dermatologists run free skin cancer screening events in many communities, including the American Academy of Dermatology's SPOTme program, which offers no-cost visual exams — a reasonable option for a one-time look if you have no regular dermatologist. Community skin cancer screening programs at hospitals and health fairs work the same way, and are often advertised most heavily in the late spring around skin-cancer awareness campaigns.

For ongoing care, whether a full-body skin check is covered by insurance usually turns on why it is done: an exam prompted by a specific concerning spot is typically billed as a diagnostic visit and covered like other medical care, while a routine screening with no symptoms may or may not be covered, depending on the plan and your risk history. Because the same visit can be billed either way, it is worth asking, before the appointment, whether it will count as screening or diagnostic and what your share of the cost will be. A screening that finds something and turns into a biopsy can also generate a separate pathology bill, so it is fair to ask how that would be handled too.